|
Volumn 14, Issue 5, 2004, Pages 1109-1113
|
Development of novel lipid-peptide hybrid compounds with antibacterial activity from natural cationic antibacterial peptides
|
Author keywords
Antibacterial peptide; Lipid peptide hybrid compound; Net positive charge; Stability; Structural parameters
|
Indexed keywords
ACETIC ACID DERIVATIVE;
AMINOCAPROIC ACID DERIVATIVE;
ANTIINFECTIVE AGENT;
BENZOIC ACID DERIVATIVE;
DEPSIPEPTIDE;
FATTY ACID;
FATTY ACID DERIVATIVE;
GLYCINE;
LEUCINE;
LYSINE;
LYSYLLYSYLTYROSYLCYSTEINYLASPARAGINYLGLYCYLLYSYLARGINYLVALYLCYSTEINYLVALYLC YSTEINYLARGININAMIDE;
LYSYLLYSYLTYROSYLISOLEUCYLLYSYLVALYLPHENYLALANYLVALYLPHENYLALANYLLYSINAMIDE;
LYSYLPHENYLALANYLTYROSYLCYSTEINYLASPARAGINYLGLYCYLLYSYLARGINYLVALYLCYSTEINY LVALYLCYSTEINYLARGININAMIDE;
LYSYLTYROSYLCYSTEINYLASPARAGINYLGLYCYLLYSYLARGINYLVALYLCYSTEINYLVALYLCYSTEI NYLARGININAMIDE;
PALMITOLEIC ACID DERIVATIVE;
PEPTIDE DERIVATIVE;
PHENYLALANINE;
PHENYLALANYLTYROSYLCYSTEINYLASPARAGINYLGLYCYLLYSYLARGINYLVALYLCYSTEINYLVALY LCYSTEINYLARGININAMIDE;
PROLINE;
SERINE;
TYROSYLCYSTEINYLASPARAGINYLGLYCYLLYSYLARGINYLVALYLCYSTEINYLVALYLCYSTEINYLAR GININAMIDE;
UNCLASSIFIED DRUG;
VALINE;
AMINO TERMINAL SEQUENCE;
ANIMAL CELL;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BETA SHEET;
BIOAVAILABILITY;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG POTENCY;
DRUG SYNTHESIS;
MOUSE;
NONHUMAN;
STAPHYLOCOCCUS AUREUS;
ILEX COOKII;
STAPHYLOCOCCUS;
STAPHYLOCOCCUS AUREUS;
|
EID: 1242339559
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2003.12.085 Document Type: Article |
Times cited : (17)
|
References (25)
|